Skip to main content
Clinical Trials/NCT02139917
NCT02139917CompletedNot Applicable

Effects of a Transitional Palliative Care Model on Patients With ESRF

The Hong Kong Polytechnic University1 site in 1 country76 target enrollmentStarted: August 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
76
Locations
1
Primary Endpoint
Healthcare utilization composite - The dates of re-hospitalizations, length of stay, and number of other hospital services used, including clinics and emergency room visits, will be extracted from the hospital administrative systems.

Study Overview

Brief Summary

Primary aim:

  1. To compare the effects of customary care and an interventional Home-based Palliative Renal Program (HBPRP) for ESRF patients
  2. To compare the effects of customary care and Home-based Palliative Program (HBPP) for ESRF patients

Secondary aim: 3. To explore the lived experiences of patients with ESRF. Hypothesis The transitional renal palliative care model is associated with decreased in unscheduled hospital readmission, reduce length of stay as well as improved quality of life for patients with end-stage renal failure.

Detailed Description

Objectives

Related to the primary aim:

  1. Are there differences in healthcare utilization between the ESRF patients in the customary care group and those in the HBPRP group; in the HBPRP group and HBPP group?
  2. Are there differences in evaluated health outcomes (functional status, symptom intensity, and satisfaction with care) between the customary care group and the HBPRP group ; in the HBPRP group and HBPP group?
  3. Are there differences in perceived health outcomes (quality of life, caregiver burden) between the customary care group and the HBPRP group; in the HBPRP group and HBPP group?

Related to the secondary aim: 4. How are the lived experiences compared and contrasted between the customary care group and the HBPRP group; in the HBPRP group and HBPP group?

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient with chronic kidney disease and diabetic mellitus with Creatinine ≥350 milli mole (uM) or those without diabetic mellitus with Creatinine ≥450 milli mole (uM) who refused renal replacement therapy (RRT);
  • •Patient not suitable for long term renal replacement therapy (RRT) after assessment by renal team (e.g. multiple co morbidities, poor functional status and social support)
  • •Identified as ESRF patient eligible for palliative care without prior renal replacement therapy
  • •Ability to speak Cantonese
  • •Living within the hospital service area
  • •Ability to be contacted by phone

Exclusion Criteria

  • •Discharged to nursing home or other institution
  • •Inability to communicate
  • •Cognitive impairment, mini mental stage examination (MMSE) < 20
  • •Diagnosed with severe psychiatric disorders such as schizophrenia and bipolar disorder

Arms & Interventions

Transitional Palliative Care

Experimental

Transitional palliative care include:-

  • telephone follow up for early identification of signs and symptoms
  • home visit for spiritual support

Intervention: Transitional community based palliative care (Behavioral)

Customary care

No Intervention

Customary care receive care :-

  • hospital based medical follow up
  • general nursing assessment and advice

Outcomes

Primary Outcomes

Healthcare utilization composite - The dates of re-hospitalizations, length of stay, and number of other hospital services used, including clinics and emergency room visits, will be extracted from the hospital administrative systems.

Time Frame: for 12 months

Secondary Outcomes

  • Evaluated health outcomes composite (functional status, symptom intensity) - The functional status will be measured by the Palliative Performance Scale (PPS )(appendix 6).(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

TAM Mee Ling Bonnie

Clinical Associate

The Hong Kong Polytechnic University

Study Sites (1)

Loading locations...

Similar Trials